Cargando…

Toward G protein-coupled receptor structure-based drug design using X-ray lasers

Rational structure-based drug design (SBDD) relies on the availability of a large number of co-crystal structures to map the ligand-binding pocket of the target protein and use this information for lead-compound optimization via an iterative process. While SBDD has proven successful for many drug-di...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishchenko, Andrii, Stauch, Benjamin, Han, Gye Won, Batyuk, Alexander, Shiriaeva, Anna, Li, Chufeng, Zatsepin, Nadia, Weierstall, Uwe, Liu, Wei, Nango, Eriko, Nakane, Takanori, Tanaka, Rie, Tono, Kensuke, Joti, Yasumasa, Iwata, So, Moraes, Isabel, Gati, Cornelius, Cherezov, Vadim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830214/
https://www.ncbi.nlm.nih.gov/pubmed/31709066
http://dx.doi.org/10.1107/S2052252519013137
_version_ 1783465736217296896
author Ishchenko, Andrii
Stauch, Benjamin
Han, Gye Won
Batyuk, Alexander
Shiriaeva, Anna
Li, Chufeng
Zatsepin, Nadia
Weierstall, Uwe
Liu, Wei
Nango, Eriko
Nakane, Takanori
Tanaka, Rie
Tono, Kensuke
Joti, Yasumasa
Iwata, So
Moraes, Isabel
Gati, Cornelius
Cherezov, Vadim
author_facet Ishchenko, Andrii
Stauch, Benjamin
Han, Gye Won
Batyuk, Alexander
Shiriaeva, Anna
Li, Chufeng
Zatsepin, Nadia
Weierstall, Uwe
Liu, Wei
Nango, Eriko
Nakane, Takanori
Tanaka, Rie
Tono, Kensuke
Joti, Yasumasa
Iwata, So
Moraes, Isabel
Gati, Cornelius
Cherezov, Vadim
author_sort Ishchenko, Andrii
collection PubMed
description Rational structure-based drug design (SBDD) relies on the availability of a large number of co-crystal structures to map the ligand-binding pocket of the target protein and use this information for lead-compound optimization via an iterative process. While SBDD has proven successful for many drug-discovery projects, its application to G protein-coupled receptors (GPCRs) has been limited owing to extreme difficulties with their crystallization. Here, a method is presented for the rapid determination of multiple co-crystal structures for a target GPCR in complex with various ligands, taking advantage of the serial femtosecond crystallography approach, which obviates the need for large crystals and requires only submilligram quantities of purified protein. The method was applied to the human β(2)-adrenergic receptor, resulting in eight room-temperature co-crystal structures with six different ligands, including previously unreported structures with carvedilol and propranolol. The generality of the proposed method was tested with three other receptors. This approach has the potential to enable SBDD for GPCRs and other difficult-to-crystallize membrane proteins.
format Online
Article
Text
id pubmed-6830214
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-68302142019-11-08 Toward G protein-coupled receptor structure-based drug design using X-ray lasers Ishchenko, Andrii Stauch, Benjamin Han, Gye Won Batyuk, Alexander Shiriaeva, Anna Li, Chufeng Zatsepin, Nadia Weierstall, Uwe Liu, Wei Nango, Eriko Nakane, Takanori Tanaka, Rie Tono, Kensuke Joti, Yasumasa Iwata, So Moraes, Isabel Gati, Cornelius Cherezov, Vadim IUCrJ Research Papers Rational structure-based drug design (SBDD) relies on the availability of a large number of co-crystal structures to map the ligand-binding pocket of the target protein and use this information for lead-compound optimization via an iterative process. While SBDD has proven successful for many drug-discovery projects, its application to G protein-coupled receptors (GPCRs) has been limited owing to extreme difficulties with their crystallization. Here, a method is presented for the rapid determination of multiple co-crystal structures for a target GPCR in complex with various ligands, taking advantage of the serial femtosecond crystallography approach, which obviates the need for large crystals and requires only submilligram quantities of purified protein. The method was applied to the human β(2)-adrenergic receptor, resulting in eight room-temperature co-crystal structures with six different ligands, including previously unreported structures with carvedilol and propranolol. The generality of the proposed method was tested with three other receptors. This approach has the potential to enable SBDD for GPCRs and other difficult-to-crystallize membrane proteins. International Union of Crystallography 2019-10-24 /pmc/articles/PMC6830214/ /pubmed/31709066 http://dx.doi.org/10.1107/S2052252519013137 Text en © Andrii Ishchenko et al. 2019 http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.http://creativecommons.org/licenses/by/4.0/
spellingShingle Research Papers
Ishchenko, Andrii
Stauch, Benjamin
Han, Gye Won
Batyuk, Alexander
Shiriaeva, Anna
Li, Chufeng
Zatsepin, Nadia
Weierstall, Uwe
Liu, Wei
Nango, Eriko
Nakane, Takanori
Tanaka, Rie
Tono, Kensuke
Joti, Yasumasa
Iwata, So
Moraes, Isabel
Gati, Cornelius
Cherezov, Vadim
Toward G protein-coupled receptor structure-based drug design using X-ray lasers
title Toward G protein-coupled receptor structure-based drug design using X-ray lasers
title_full Toward G protein-coupled receptor structure-based drug design using X-ray lasers
title_fullStr Toward G protein-coupled receptor structure-based drug design using X-ray lasers
title_full_unstemmed Toward G protein-coupled receptor structure-based drug design using X-ray lasers
title_short Toward G protein-coupled receptor structure-based drug design using X-ray lasers
title_sort toward g protein-coupled receptor structure-based drug design using x-ray lasers
topic Research Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6830214/
https://www.ncbi.nlm.nih.gov/pubmed/31709066
http://dx.doi.org/10.1107/S2052252519013137
work_keys_str_mv AT ishchenkoandrii towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers
AT stauchbenjamin towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers
AT hangyewon towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers
AT batyukalexander towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers
AT shiriaevaanna towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers
AT lichufeng towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers
AT zatsepinnadia towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers
AT weierstalluwe towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers
AT liuwei towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers
AT nangoeriko towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers
AT nakanetakanori towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers
AT tanakarie towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers
AT tonokensuke towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers
AT jotiyasumasa towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers
AT iwataso towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers
AT moraesisabel towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers
AT gaticornelius towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers
AT cherezovvadim towardgproteincoupledreceptorstructurebaseddrugdesignusingxraylasers